Cargando…

The development of a scoring and ranking strategy for a patient-tailored adverse drug reaction prediction in polypharmacy

Only few applications are currently dealing with personalized adverse drug reactions (ADRs) prediction in case of polypharmacy. The study aimed to develop a patient-tailored ADR web application, considering characteristics from 734 drugs and relevant patient related factors. The application was desi...

Descripción completa

Detalles Bibliográficos
Autores principales: Valeanu, Andrei, Damian, Cristian, Marineci, Cristina Daniela, Negres, Simona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293306/
https://www.ncbi.nlm.nih.gov/pubmed/32533040
http://dx.doi.org/10.1038/s41598-020-66611-8
_version_ 1783546275191324672
author Valeanu, Andrei
Damian, Cristian
Marineci, Cristina Daniela
Negres, Simona
author_facet Valeanu, Andrei
Damian, Cristian
Marineci, Cristina Daniela
Negres, Simona
author_sort Valeanu, Andrei
collection PubMed
description Only few applications are currently dealing with personalized adverse drug reactions (ADRs) prediction in case of polypharmacy. The study aimed to develop a patient-tailored ADR web application, considering characteristics from 734 drugs and relevant patient related factors. The application was designed in Python using a scoring and ranking system based on frequency and severity, computed for each ADR and expressed through an online platform. A neural networks algorithm was used for predicting the severity of ADRs. The application inputs are: age, gender, drugs, relevant pathologies. The outputs are: an overall severity profile (hospitalization and mortality risk), a stratified risk on specific ADR groups and a sorted list of the most important ADRs depending on frequency and severity. The Severity prediction model validation resulted in 79.7–85.1% Area Under the Receiver Operating Characteristic Curve Score, which lies in the good cut-off of 75–90%. The program offers a complex view regarding the ADR profile of a given patient and could be used by the physician and clinical pharmacist during patient safety monitoring, for a coherent therapy choice or medication adjustment, due to the good therapy coverage and the inclusion of relevant patient comorbidities.
format Online
Article
Text
id pubmed-7293306
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-72933062020-06-15 The development of a scoring and ranking strategy for a patient-tailored adverse drug reaction prediction in polypharmacy Valeanu, Andrei Damian, Cristian Marineci, Cristina Daniela Negres, Simona Sci Rep Article Only few applications are currently dealing with personalized adverse drug reactions (ADRs) prediction in case of polypharmacy. The study aimed to develop a patient-tailored ADR web application, considering characteristics from 734 drugs and relevant patient related factors. The application was designed in Python using a scoring and ranking system based on frequency and severity, computed for each ADR and expressed through an online platform. A neural networks algorithm was used for predicting the severity of ADRs. The application inputs are: age, gender, drugs, relevant pathologies. The outputs are: an overall severity profile (hospitalization and mortality risk), a stratified risk on specific ADR groups and a sorted list of the most important ADRs depending on frequency and severity. The Severity prediction model validation resulted in 79.7–85.1% Area Under the Receiver Operating Characteristic Curve Score, which lies in the good cut-off of 75–90%. The program offers a complex view regarding the ADR profile of a given patient and could be used by the physician and clinical pharmacist during patient safety monitoring, for a coherent therapy choice or medication adjustment, due to the good therapy coverage and the inclusion of relevant patient comorbidities. Nature Publishing Group UK 2020-06-12 /pmc/articles/PMC7293306/ /pubmed/32533040 http://dx.doi.org/10.1038/s41598-020-66611-8 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Valeanu, Andrei
Damian, Cristian
Marineci, Cristina Daniela
Negres, Simona
The development of a scoring and ranking strategy for a patient-tailored adverse drug reaction prediction in polypharmacy
title The development of a scoring and ranking strategy for a patient-tailored adverse drug reaction prediction in polypharmacy
title_full The development of a scoring and ranking strategy for a patient-tailored adverse drug reaction prediction in polypharmacy
title_fullStr The development of a scoring and ranking strategy for a patient-tailored adverse drug reaction prediction in polypharmacy
title_full_unstemmed The development of a scoring and ranking strategy for a patient-tailored adverse drug reaction prediction in polypharmacy
title_short The development of a scoring and ranking strategy for a patient-tailored adverse drug reaction prediction in polypharmacy
title_sort development of a scoring and ranking strategy for a patient-tailored adverse drug reaction prediction in polypharmacy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293306/
https://www.ncbi.nlm.nih.gov/pubmed/32533040
http://dx.doi.org/10.1038/s41598-020-66611-8
work_keys_str_mv AT valeanuandrei thedevelopmentofascoringandrankingstrategyforapatienttailoredadversedrugreactionpredictioninpolypharmacy
AT damiancristian thedevelopmentofascoringandrankingstrategyforapatienttailoredadversedrugreactionpredictioninpolypharmacy
AT marinecicristinadaniela thedevelopmentofascoringandrankingstrategyforapatienttailoredadversedrugreactionpredictioninpolypharmacy
AT negressimona thedevelopmentofascoringandrankingstrategyforapatienttailoredadversedrugreactionpredictioninpolypharmacy
AT valeanuandrei developmentofascoringandrankingstrategyforapatienttailoredadversedrugreactionpredictioninpolypharmacy
AT damiancristian developmentofascoringandrankingstrategyforapatienttailoredadversedrugreactionpredictioninpolypharmacy
AT marinecicristinadaniela developmentofascoringandrankingstrategyforapatienttailoredadversedrugreactionpredictioninpolypharmacy
AT negressimona developmentofascoringandrankingstrategyforapatienttailoredadversedrugreactionpredictioninpolypharmacy